Synthesis and characterization of thiolated HA. Thiolated HA (HA-SH) was synthesized and characterized as described elsewhere [S2] . HA (MW = 100 kDa) was dissolved in water (5 mg/mL) and conjugated with cystamine dihydrochloride at pH 4.8 for 6 h after activation of the carboxyl group of HA with EDC and HOBT. The resulting product was poured into the pre-washed dialysis membrane tube (MWCO of 7 kDa) and dialyzed against a large excess amount of water. Then, TCEP was added to the solution to reduce the disulfide bond of cystamine grafted HA at pH 7. After stirring for 3 h, the pH of the solution was dropped to 3.5 by the addition of 0.1 N HCl. Finally, HA-SH was precipitated in the excess ethanol, re-dissolved in water, and freeze-dried for 3 days. The degree of thiol modification was determined by 1 H NMR.
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Synthesis and characterization of HA hydrogels. HA-AEMA and HA-SH were dissolved in PBS at a concentration of 4 wt%, respectively. HA hydrogel was formed by simple mixing of HA-AEMA and HA-SH solutions. The sol-gel transition was determined by a flow test utilizing the test tube inversion method. For the determination of crosslinking density, HA hydrogel fabricated in the 1 mL syringe was degraded with hyaluronidase (100 U/mL) and the remaining unreacted thiol group and methacryloyl group were analyzed by 1 H NMR. In addition, the gelation process and the mechanical property of HA hydrogels were characterized by the rheological analysis at 25°C with a TA ARES rheometer having a parallel-plate geometry (25 mm diameter). The gelation process was monitored by measuring storage (G') and loss (G'') moduli of the HA hydrogel precursor solution (2 wt%) at a constant frequency of 50 rad s -1 and a fixed strain amplitude (10 %) with increasing time. Then, HA hydrogel prepared with 4 wt% HA precursor solution was cured for 3 h, and the storage (G') and loss (G'') moduli were analyzed by frequency sweep rheology.
In vitro release test of hGH. HA-AEMA and HA-SH were dissolved in PBS at a concentration of 4 wt%, respectively. HA hydrogels encapsulating hGH was prepared by simple mixing of HA-AEMA and HA-SH solutions (each 100 μL) with hGH solution (15 mg/mL, 50 μL) at a final hGH concentration of 3 mg/mL in a syringe. After incubation for 10 min, the HA hydrogel was put into 20 mL of fresh PBS in a vial. The amount of released hGH at predetermined time intervals was measured by Bradford protein assay and ELISA.
Characterization of in vitro released hGH. In vitro released hGH was characterized by reverse phased -high performance liquid chromatography (RP-HPLC) and circular dichroism (CD). RP-HPLC analysis was performed using the following systems: Waters 717 plus autosampler, Waters 1525 binary HPLC pump, Waters 2487 dual absorbance detector, Waters symmetry 300 TM C 4 column. As a mobile phase, 0.05 M Tris (pH 7.5)/n-propanol (71/29) was used at a flow rate of 0.5 ml/min. The detection wavelength was 280 nm. CD spectra for hGH in PBS (pH 7.4) were obtained with a UV spectrophotometer (JASCO J-715) at 25°C over the wavelength range of 200 ~ 250 nm under a nitrogen atmosphere. A quartz cuvette with a path length of 2 mm was used. Raw data were acquired at 0.2 mm intervals with a response time of 1 s. Each spectrum was subtracted by the spectrum of PBS and the residual ellipticity was calculated as an average of three scans.
In vivo release test of hGH in SD rats. As a preliminary study, in situ HA hydrogel formation was confirmed by anatomization 10 min after mixing and subcutaneous (sc) injection of HA-AEMA and HA-SH solutions (each 200 μL) at a concentration of 4 wt% to female SD rats. After that, female SD rats at a mean body weight of 300 g were divided into three groups (five animals in each group). Group 1 was treated by sc injection of PBS as a control. Group 2 was treated by sc injection of the precursor solution of HA-AEMA (200 μL), HA-SH (200 μL), and hGH (15 mg/mL, 100 μL). Group 3 was treated by sc surgical implantation of hGH loaded HA bulk hydrogels (500 μL) prepared as described above. In both cases, the injected dose of hGH was 5 mg/kg-body weight.
